Skip to main content

Table 4 Odds ratio and 95% CI of hyperuricemia at 3-year follow-up according to baseline hemoglobin quartiles

From: Hemoglobin concentration is associated with the incidence of metabolic syndrome

Women

Q1 (< 132 g/L)

Q2 (132-138g/L)

Q3 (139-144g/L)

Q4 (≥145 g/L)

Uric acid

n = 1092

n = 1226

n = 1004

n = 1071

Incidence (%)

170 (15.6)

229 (18.7)

216 (21.5)

270 (25.2)

Model 1

1 (Ref)

1.25 (1.00–1.55) *

1.49 (1.19–1.86) *

1.83 (1.48–2.26) *

Model 2

1 (Ref)

1.15 (0.92–1.44)

1.45 (1.15–1.82) *

1.68 (1.35–2.10) *

Model 3

1 (Ref)

1.00 (0.79–1.27)

1.20 (0.94–1.53)

1.23 (0.97–1.57)

Men

Q1 (< 152 g/L)

Q2 (152-158g/L)

Q3 (159-165g/L)

Q4 (≥166 g/L)

Uric acid

n = 535

n = 513

n = 522

n = 472

Incidence (%)

139 (26.0)

156 (30.4)

173 (33.1)

157 (33.3)

Model 1

1 (Ref)

1.25 (0.95–1.63)

1.41 (1.08–1.84) *

1.42 (1.08–1.86) *

Model 2

1 (Ref)

1.24 (0.94–1.64)

1.41 (1.07–1.85) *

1.37 (1.04–1.82) *

Model 3

1 (Ref)

1.19 (0.89–1.58)

1.20 (0 .90–1.60)

1.15 (0.85–1.56)

  1. Abbreviations: CI, confidential interval; the use of bold emphasis and * are to mark the statistically significant indicators
  2. Model 1 is unadjusted;
  3. Model 2 is adjusted for age, education, smoking and drinking;
  4. Model 3 is adjusted for age, education, smoking, drinking, WC, SBP, DBP, FPG, HDL-c, TGs, NAFLD and eGFR